Annual Cash & Cash Equivalents
$853.90 M
-$40.40 M-4.52%
31 December 2023
Summary:
West Pharmaceutical Services annual cash & cash equivalents is currently $853.90 million, with the most recent change of -$40.40 million (-4.52%) on 31 December 2023. During the last 3 years, it has risen by +$238.40 million (+38.73%). WST annual cash & cash equivalents is now -4.52% below its all-time high of $894.30 million, reached on 31 December 2022.WST Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$490.90 M
+$44.70 M+10.02%
30 September 2024
Summary:
West Pharmaceutical Services quarterly cash and cash equivalents is currently $490.90 million, with the most recent change of +$44.70 million (+10.02%) on 30 September 2024. Over the past year, it has dropped by -$407.70 million (-45.37%). WST quarterly cash and cash equivalents is now -45.37% below its all-time high of $898.60 million, reached on 30 September 2023.WST Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WST Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.5% | -45.4% |
| 3 y3 years | +38.7% | -28.6% |
| 5 y5 years | +153.1% | +24.0% |
WST Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.5% | +38.7% | -45.4% | +10.0% |
| 5 y | 5 years | -4.5% | +153.1% | -45.4% | +46.4% |
| alltime | all time | -4.5% | >+9999.0% | -45.4% | >+9999.0% |
West Pharmaceutical Services Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $490.90 M(+10.0%) |
| June 2024 | - | $446.20 M(-25.9%) |
| Mar 2024 | - | $601.80 M(-29.5%) |
| Dec 2023 | $853.90 M(-4.5%) | $853.90 M(-5.0%) |
| Sept 2023 | - | $898.60 M(+12.8%) |
| June 2023 | - | $796.30 M(-10.2%) |
| Mar 2023 | - | $886.30 M(-0.9%) |
| Dec 2022 | $894.30 M(+17.3%) | $894.30 M(+22.7%) |
| Sept 2022 | - | $729.00 M(+1.5%) |
| June 2022 | - | $718.50 M(+7.6%) |
| Mar 2022 | - | $667.70 M(-12.4%) |
| Dec 2021 | $762.60 M(+23.9%) | $762.60 M(+10.8%) |
| Sept 2021 | - | $688.00 M(+19.4%) |
| June 2021 | - | $576.20 M(+19.1%) |
| Mar 2021 | - | $483.70 M(-21.4%) |
| Dec 2020 | $615.50 M(+40.2%) | $615.50 M(+18.5%) |
| Sept 2020 | - | $519.40 M(+16.5%) |
| June 2020 | - | $445.90 M(+33.0%) |
| Mar 2020 | - | $335.30 M(-23.6%) |
| Dec 2019 | $439.10 M(+30.1%) | $439.10 M(+10.9%) |
| Sept 2019 | - | $396.00 M(+21.2%) |
| June 2019 | - | $326.70 M(+23.1%) |
| Mar 2019 | - | $265.50 M(-21.3%) |
| Dec 2018 | $337.40 M(+43.0%) | $337.40 M(+13.5%) |
| Sept 2018 | - | $297.30 M(+31.8%) |
| June 2018 | - | $225.50 M(+12.9%) |
| Mar 2018 | - | $199.80 M(-15.3%) |
| Dec 2017 | $235.90 M(+16.2%) | $235.90 M(-12.4%) |
| Sept 2017 | - | $269.30 M(+18.8%) |
| June 2017 | - | $226.60 M(+33.8%) |
| Mar 2017 | - | $169.40 M(-16.6%) |
| Dec 2016 | $203.00 M(-26.1%) | $203.00 M(-1.4%) |
| Sept 2016 | - | $205.90 M(+1.6%) |
| June 2016 | - | $202.70 M(+13.8%) |
| Mar 2016 | - | $178.10 M(-35.1%) |
| Dec 2015 | $274.60 M(+7.6%) | $274.60 M(+6.9%) |
| Sept 2015 | - | $256.80 M(+1.9%) |
| June 2015 | - | $252.00 M(+21.7%) |
| Mar 2015 | - | $207.10 M(-18.9%) |
| Dec 2014 | $255.30 M(+11.0%) | $255.30 M(+3.4%) |
| Sept 2014 | - | $246.80 M(+8.9%) |
| June 2014 | - | $226.70 M(-1.4%) |
| Mar 2014 | - | $230.00 M(0.0%) |
| Dec 2013 | $230.00 M(+42.1%) | $230.00 M(+3.7%) |
| Sept 2013 | - | $221.70 M(+16.3%) |
| June 2013 | - | $190.60 M(+8.9%) |
| Mar 2013 | - | $175.00 M(+8.1%) |
| Dec 2012 | $161.90 M(+76.4%) | $161.90 M(+13.1%) |
| Sept 2012 | - | $143.20 M(+33.8%) |
| June 2012 | - | $107.00 M(+6.8%) |
| Mar 2012 | - | $100.20 M(+9.2%) |
| Dec 2011 | $91.80 M(-16.7%) | $91.80 M(-23.0%) |
| Sept 2011 | - | $119.20 M(+8.0%) |
| June 2011 | - | $110.40 M(+16.7%) |
| Mar 2011 | - | $94.60 M(-14.2%) |
| Dec 2010 | $110.20 M(+32.6%) | $110.20 M(+13.5%) |
| Sept 2010 | - | $97.10 M(+43.9%) |
| June 2010 | - | $67.50 M(+2.4%) |
| Mar 2010 | - | $65.90 M(-20.7%) |
| Dec 2009 | $83.10 M(-4.7%) | $83.10 M(+4.5%) |
| Sept 2009 | - | $79.50 M(-5.7%) |
| June 2009 | - | $84.30 M(+34.4%) |
| Mar 2009 | - | $62.70 M(-28.1%) |
| Dec 2008 | $87.20 M(-19.6%) | $87.20 M(-14.9%) |
| Sept 2008 | - | $102.50 M(+0.2%) |
| June 2008 | - | $102.30 M(+9.3%) |
| Mar 2008 | - | $93.60 M(-13.7%) |
| Dec 2007 | $108.40 M(+130.1%) | $108.40 M(-28.4%) |
| Sept 2007 | - | $151.40 M(-14.6%) |
| June 2007 | - | $177.30 M(+13.2%) |
| Mar 2007 | - | $156.60 M(+232.5%) |
| Dec 2006 | $47.10 M | $47.10 M(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $44.80 M(-2.8%) |
| June 2006 | - | $46.10 M(+47.3%) |
| Mar 2006 | - | $31.30 M(-35.9%) |
| Dec 2005 | $48.80 M(-29.1%) | $48.80 M(+133.5%) |
| Sept 2005 | - | $20.90 M(-66.0%) |
| June 2005 | - | $61.50 M(+13.9%) |
| Mar 2005 | - | $54.00 M(-21.5%) |
| Dec 2004 | $68.80 M(+82.0%) | $68.80 M(+8.7%) |
| Sept 2004 | - | $63.30 M(+19.7%) |
| June 2004 | - | $52.90 M(+30.3%) |
| Mar 2004 | - | $40.60 M(+7.4%) |
| Dec 2003 | $37.80 M(+13.9%) | $37.80 M(-30.6%) |
| Sept 2003 | - | $54.50 M(+23.0%) |
| June 2003 | - | $44.30 M(+19.4%) |
| Mar 2003 | - | $37.10 M(+11.7%) |
| Dec 2002 | $33.20 M(-21.1%) | $33.20 M(-7.0%) |
| Sept 2002 | - | $35.70 M(+27.5%) |
| June 2002 | - | $28.00 M(-3.1%) |
| Mar 2002 | - | $28.90 M(-31.4%) |
| Dec 2001 | $42.10 M(-1.4%) | $42.10 M(+1.2%) |
| Sept 2001 | - | $41.60 M(+5.9%) |
| June 2001 | - | $39.30 M(+4.0%) |
| Mar 2001 | - | $37.80 M(-11.5%) |
| Dec 2000 | $42.70 M(-5.7%) | $42.70 M(+2.6%) |
| Sept 2000 | - | $41.60 M(+11.5%) |
| June 2000 | - | $37.30 M(-32.2%) |
| Mar 2000 | - | $55.00 M(+21.4%) |
| Dec 1999 | $45.30 M(+44.7%) | $45.30 M(+20.8%) |
| Sept 1999 | - | $37.50 M(-5.3%) |
| June 1999 | - | $39.60 M(+20.0%) |
| Mar 1999 | - | $33.00 M(+5.4%) |
| Dec 1998 | $31.30 M(-40.2%) | $31.30 M(-37.4%) |
| Sept 1998 | - | $50.00 M(+2.9%) |
| June 1998 | - | $48.60 M(-26.8%) |
| Mar 1998 | - | $66.40 M(+27.0%) |
| Dec 1997 | $52.30 M(+90.9%) | $52.30 M(-1.5%) |
| Sept 1997 | - | $53.10 M(+28.3%) |
| June 1997 | - | $41.40 M(+43.3%) |
| Mar 1997 | - | $28.90 M(+5.5%) |
| Dec 1996 | $27.40 M(+57.5%) | $27.40 M(+24.0%) |
| Sept 1996 | - | $22.10 M(+47.3%) |
| June 1996 | - | $15.00 M(+5.6%) |
| Mar 1996 | - | $14.20 M(-18.4%) |
| Dec 1995 | $17.40 M(-36.0%) | $17.40 M(+0.6%) |
| Sept 1995 | - | $17.30 M(+13.1%) |
| June 1995 | - | $15.30 M(-47.1%) |
| Mar 1995 | - | $28.90 M(+6.3%) |
| Dec 1994 | $27.20 M(+423.1%) | $27.20 M(+76.6%) |
| Sept 1994 | - | $15.40 M(+75.0%) |
| June 1994 | - | $8.80 M(+27.5%) |
| Mar 1994 | - | $6.90 M(+32.7%) |
| Dec 1993 | $5.20 M(+73.3%) | $5.20 M(+116.7%) |
| Sept 1993 | - | $2.40 M(-4.0%) |
| June 1993 | - | $2.50 M(-51.9%) |
| Mar 1993 | - | $5.20 M(+73.3%) |
| Dec 1992 | $3.00 M(+11.1%) | $3.00 M(+100.0%) |
| Sept 1992 | - | $1.50 M(-21.1%) |
| June 1992 | - | $1.90 M(+72.7%) |
| Mar 1992 | - | $1.10 M(-59.3%) |
| Dec 1991 | $2.70 M(+22.7%) | $2.70 M(+107.7%) |
| Sept 1991 | - | $1.30 M(+160.0%) |
| June 1991 | - | $500.00 K(+66.7%) |
| Mar 1991 | - | $300.00 K(-86.4%) |
| Dec 1990 | $2.20 M(+37.5%) | $2.20 M(-15.4%) |
| Sept 1990 | - | $2.60 M(-3.7%) |
| June 1990 | - | $2.70 M(+145.5%) |
| Mar 1990 | - | $1.10 M(-31.3%) |
| Dec 1989 | $1.60 M(-68.6%) | $1.60 M(-68.6%) |
| Dec 1988 | $5.10 M(-59.8%) | $5.10 M(-59.8%) |
| Dec 1987 | $12.70 M(+71.6%) | $12.70 M(+71.6%) |
| Dec 1986 | $7.40 M(-12.9%) | $7.40 M(-12.9%) |
| Dec 1985 | $8.50 M(+102.4%) | $8.50 M(+102.4%) |
| Dec 1984 | $4.20 M | $4.20 M |
FAQ
- What is West Pharmaceutical Services annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual cash & cash equivalents year-on-year change?
- What is West Pharmaceutical Services quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly cash and cash equivalents year-on-year change?
What is West Pharmaceutical Services annual cash & cash equivalents?
The current annual cash & cash equivalents of WST is $853.90 M
What is the all time high annual cash & cash equivalents for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual cash & cash equivalents is $894.30 M
What is West Pharmaceutical Services annual cash & cash equivalents year-on-year change?
Over the past year, WST annual cash & cash equivalents has changed by -$40.40 M (-4.52%)
What is West Pharmaceutical Services quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of WST is $490.90 M
What is the all time high quarterly cash and cash equivalents for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly cash and cash equivalents is $898.60 M
What is West Pharmaceutical Services quarterly cash and cash equivalents year-on-year change?
Over the past year, WST quarterly cash and cash equivalents has changed by -$407.70 M (-45.37%)